Biomarin Pharmaceutical Inc (BMRN) Financials
$64.65
$0.02
(0.03%)
As on 09-Sep-2026 10:35EDT
Market cap
$12,878 Mln
Revenue (TTM)
$3,407 Mln
P/E Ratio
179.8
P/B Ratio
2.1
Div. Yield
0 %
Income Statement ($ Mln) |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
3,406.61
|
3,221.25
|
2,853.92
|
2,419.23
|
2,096.04
|
1,846.28
|
|
|
|
|
|
|
Cost of Revenue
|
832.97
|
736.83
|
580.24
|
532.06
|
503.02
|
470.52
|
|
|
|
|
|
|
Gross Profit
|
2,573.64
|
2,484.43
|
2,273.68
|
1,887.16
|
1,593.02
|
1,375.76
|
|
|
|
|
|
|
Operating Expenses
|
2,300.38
|
1,950.95
|
1,789.47
|
1,701.39
|
1,432.04
|
1,458.10
|
|
|
|
|
|
|
Operating Profit (EBIT)
|
273.26
|
533.48
|
484.21
|
185.77
|
160.97
|
-82.34
|
|
|
|
|
|
|
Other Income
|
--
|
--
|
--
|
--
|
--
|
10.48
|
|
|
|
|
|
|
Profit before Tax
|
149.11
|
482.48
|
541.76
|
188.56
|
149.58
|
-75.35
|
|
|
|
|
|
|
Provision for Tax
|
76.14
|
133.58
|
114.90
|
20.92
|
8.02
|
-11.27
|
|
|
|
|
|
|
Profit after Tax (Net Income)
|
72.97
|
348.90
|
426.86
|
167.65
|
141.56
|
-64.08
|
|
|
|
|
|
|
Minority Interest
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Consolidated Profit
|
--
|
--
|
--
|
--
|
141.56
|
-64.08
|
|
|
|
|
|
Liabilities ($ Mln) |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
6,321.69
|
6,087.00
|
5,657.99
|
4,951.55
|
4,603.16
|
4,270.74
|
|
|
|
|
|
|
Minority Interest
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Non-Current Liabilities
|
3,737.75
|
747.99
|
723.96
|
713.03
|
1,183.03
|
1,192.76
|
|
|
|
|
|
|
Current Liabilities
|
1,664.00
|
759.03
|
606.99
|
1,177.02
|
588.88
|
539.82
|
|
|
|
|
|
|
Total Liabilities
|
13,387.44
|
7,594.02
|
6,988.94
|
6,841.60
|
6,375.07
|
6,003.33
|
|
|
|
|
|
Assets ($ Mln) |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
7,751.82
|
3,640.53
|
3,756.51
|
3,885.52
|
3,623.62
|
3,728.94
|
|
|
|
|
|
|
Current Assets
|
3,971.62
|
3,953.49
|
3,232.43
|
2,956.09
|
2,751.46
|
2,274.39
|
|
|
|
|
|
|
Total Assets
|
13,387.44
|
7,594.02
|
6,988.94
|
6,841.60
|
6,375.07
|
6,003.33
|
|
|
|
|
|
|
Total Debt*
|
4,202.20
|
642.87
|
649.47
|
1,095.75
|
1,093.39
|
1,089.54
|
|
|
|
|
|
|
Net Current Assets
|
2,307.63
|
3,194.46
|
2,625.44
|
1,779.06
|
2,162.57
|
1,734.56
|
|
|
|
|
|
Cashflow ($ Mln) |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
--
|
827.99
|
572.84
|
159.26
|
175.90
|
304.54
|
|
|
|
|
|
|
Cash Flow from Investing Activities
|
--
|
-414.24
|
136.49
|
-111.24
|
-20.03
|
-366.31
|
|
|
|
|
|
|
Cash from Financing Activities
|
--
|
-42.39
|
-526.45
|
-18.73
|
-18.65
|
-0.05
|
|
|
|
|
|
|
Net Cash Inflow / Outflow
|
--
|
--
|
--
|
--
|
--
|
-61.88
|
|
|
|
|
|
Financials Ratios |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS ($)
|
0.37
|
1.77
|
2.17
|
0.87
|
0.76
|
-0.35
|
|
|
|
|
|
|
Cash EPS ($)
|
--
|
2.17
|
2.66
|
1.41
|
1.31
|
0.24
|
|
|
|
|
|
|
Adjusted Book Value ($)
|
--
|
30.84
|
28.78
|
25.81
|
24.74
|
23.27
|
|
|
|
|
|
|
Dividend per Share ($)
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Cash Flow per Share ($)
|
--
|
4.19
|
2.91
|
0.83
|
0.95
|
1.66
|
|
|
|
|
|
|
Free Cash Flow per Share ($)
|
--
|
3.67
|
2.42
|
0.27
|
0.30
|
1.01
|
|
|
|
|
|
Profitability Ratios |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
5.35
|
6.91
|
2.86
|
2.56
|
-1.21
|
|
|
|
|
|
|
ROE (%)
|
1.18
|
5.94
|
8.05
|
3.51
|
3.19
|
-1.53
|
|
|
|
|
|
|
ROA (%)
|
0.68
|
4.79
|
6.17
|
2.54
|
2.29
|
-1.08
|
|
|
|
|
|
|
EBIT Margin (%)
|
6.83
|
15.32
|
19.42
|
8.37
|
7.80
|
-3.28
|
|
|
|
|
|
|
Net Margin (%)
|
2.14
|
10.83
|
14.96
|
6.93
|
6.75
|
-3.45
|
|
|
|
|
|
|
Cash Profit Margin (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
Growth Ratios |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
11.20
|
0.13
|
0.18
|
0.15
|
0.14
|
-0.01
|
|
|
|
|
|
|
EBIT Growth (%)
|
-72.65
|
-10.96
|
173.78
|
23.87
|
369.59
|
-181.67
|
|
|
|
|
|
|
Net Profit Growth (%)
|
-88.90
|
-18.26
|
154.62
|
18.43
|
320.91
|
-107.50
|
|
|
|
|
|
|
EPS Growth (%)
|
-88.98
|
-0.19
|
1.48
|
0.15
|
3.18
|
-1.08
|
|
|
|
|
|
|
Book Value Growth (%)
|
6.24
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
Valuation Ratios |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
179.81
|
33.62
|
30.27
|
110.33
|
136.00
|
-253.07
|
|
|
|
|
|
|
Price / Book Value
|
2.05
|
1.93
|
2.28
|
3.74
|
4.18
|
3.80
|
|
|
|
|
|
|
Dividend Yield (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
EV/EBITDA
|
42.24
|
18.87
|
19.11
|
60.37
|
71.80
|
343.49
|
|
|
|
|
|
|
Close Price ($)
|
57.22
|
59.43
|
65.73
|
96.42
|
103.49
|
88.35
|
|
|
|
|
|
|
High Price ($)
|
66.28
|
73.51
|
99.25
|
117.77
|
109.56
|
92.20
|
|
|
|
|
|
|
Low Price ($)
|
49.26
|
50.76
|
61.15
|
76.02
|
70.73
|
71.59
|
|
|
|
|
|
|
Market Cap ($ Cr)
|
12,878.46
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
Solvency Ratios |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
0.56
|
0.11
|
0.11
|
0.22
|
0.24
|
0.26
|
|
|
|
|
|
|
Short term debt to equity ratio
|
0.11
|
0.00
|
0.00
|
0.10
|
0.00
|
0.00
|
|
|
|
|
|
|
Current Ratio
|
2.39
|
5.21
|
5.33
|
2.51
|
4.67
|
4.21
|
|
|
|
|
|
|
Quick Ratio
|
1.32
|
3.50
|
3.29
|
1.57
|
3.15
|
2.77
|
|
|
|
|
|
|
Interest Coverage
|
2.78
|
45.27
|
43.75
|
11.68
|
10.23
|
-3.95
|
|
|
|
|
|
Operating Efficiency Ratios |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
31.15
|
28.19
|
23.14
|
26.19
|
22.01
|
20.22
|
|
|
|
|
|
|
Asset Turnover
|
0.32
|
0.44
|
0.41
|
0.37
|
0.34
|
0.31
|
|
|
|
|
|
|
Receivable days
|
--
|
88.94
|
82.82
|
82.66
|
72.73
|
81.28
|
|
|
|
|
|
|
Inventory Days
|
--
|
627.45
|
736.45
|
686.91
|
606.57
|
572.59
|
|
|
|
|
|
|
Payable days
|
--
|
135.87
|
173.40
|
187.67
|
154.02
|
149.21
|
|
|
|
|
|
|
Cash Conversion Cycle
|
--
|
580.52
|
645.87
|
581.91
|
525.28
|
504.66
|
|
|
|
|
|
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
